3Helix, Inc.

SEC filing

Biotechnology · Salt Lake City, UT

Form D on EDGAR

Amount raised$7.8Msold at filing

Total offering$10M$2.2M still open

Investors in the raise13count reported to the SEC

FiledSep 21, 2026first sale Aug 31, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Noah D NasserDirector

Michael KirknessExecutive Officer, Director

Nalini D KellyDirector

Michael D YuDirector

Michael D FugmanDirector

Executive officers, directors and promoters as listed on the Form D.